Scancell Holdings plc (AIM: SCLP), the developer of ImmunoBody® and Moditope® active immunotherapies to treat cancer, today announces a business update and provides its final audited financial results ...

"Software is... continuously evolving. And so you need to fund it and structure the teams that build it in a way that ...

Aflatoxins, carcinogenic secondary metabolites produced by Aspergillus species, pose serious threats to the safety and ...

What’s Bongbong Marcos’ scope in probing flood control scams? From it the public will judge his seriousness for reforms.

Silent infections - those that progress without clear clinical signs in their early stages - pose a significant challenge to ...

Congress claims TRAI blocked its protest-related SMS templates, sparking debate on transparency in promotional message ...